Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 4, 2010, Pages 590-596

  Dubey, Vaibhav ^a   Mishra, Dinesh ^a   Nahar, Manoj ^a   Jain, Vikas ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Ethanolic liposomes; Ethosomes; Indinavir; Percutaneous permeation

Indexed keywords

ANTI-HIV AGENTS; DRUG SOLUTIONS; ENTRAPMENT EFFICIENCY; ETHOSOMES; HALF LIVES; HUMAN CADAVER SKINS; INDINAVIR; LAG-TIME; NANOMETRIC SIZE; ORAL ABSORPTION; ORAL ADMINISTRATION; ORAL ROUTE; PERCUTANEOUS PERMEATION; PH-DEPENDENT; PROTEASE INHIBITOR; TRANSDERMAL DELIVERY; TRANSDERMAL FLUX; UNILAMELLAR;

BEARINGS (STRUCTURAL); BIOCHEMISTRY; PHOSPHOLIPIDS; POLYDISPERSITY;

LIPOSOMES;

ALCOHOL; ETHOSOME; INDINAVIR; LIPOSOME; UNCLASSIFIED DRUG;

ARTICLE; CADAVER; CONFOCAL LASER MICROSCOPY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; NANOANALYSIS; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ETHANOL; HIV PROTEASE INHIBITORS; INDINAVIR; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; SKIN; SKIN ABSORPTION;

EID: 77955270290     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.01.002     Document Type: Article

References (32)

1. Dou H., Destache C.J., Morehead J.R., Mosley R.L., et al. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 2006, 108:2827-2835.
2. Singh P., Premkumar L., Mehrotra R., Kandpal H.C., Bakhshi A.K. Evaluation of thermal stability of indinavir sulphate using diffuse reflectance infrared spectroscopy. J Pharm Biomed Anal 2008, 47:248-254.
3. Aarnoutse R., Schapiro J.M., Bouchr C.A.B., Hkster Y.A., Burger D.M. Therapeutic drug monitoring. Drugs 2003, 63:741-753.
4. Williams G.C., Sinko P.J. Oral absorption of the HIV protease inhibitors: a current update. Adv Drug Deliv Rev 1999, 39:211-238.
5. Schiffman S., Zervakis J., Heffron S., Heald A.S. Effect of protease inhibitors on the sense of taste. Nutrition 1999, 15:767-772.
6. Andrews L., Friedland G. Progress in the HIV therapeutics and the challenges of adherence to antiretroviral therapy. Infect Dis Clin North Am 2000, 14:1-26.
7. Magnusson B.M., Runn P., Karlsson K., Koskinen L. Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin-releasing hormone in human epidermis. Int J Pharm 1997, 157:113-121.
8. Komatsu H., Okada S. Ethanol enhanced permeation of phosphatidylcholine/phosphatidylethanolamine mixed liposomal membranes due to ethanol induced lateral phase separation. Biochim Biophys Acta 1996, 1283:73-79.
9. Panchagnula P., Salve P.R., Thomas N.S., Jain A.K., Ramarao P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 2001, 219:95-105.
10. Kadir R., Stempler D., Liron Z., Cohen S. Delivery of theophylline into excised human skin from alkanoic acid solutions: a push-pull mechanism. J. Pharm. Sci. 1987, 76:774-779.
11. Dubey V., Mishra D., Dutta T., Nahar M., Saraf D.K., Jain N.K. Dermal and transdermal delivery of an antipsoriatic agent via ethanolic liposomes. J Control Release 2007, 123:148-155.
12. Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000, 65:403-418.
13. Dubey V., Mishra D., Jain N.K. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007, 67:398-405.
14. Dubey V., Mishra D., Nahar M., Jain N.K. Vesicles as tools for the modulation of skin permeability. Expert Opin Drug Deliv 2007, 4:579-593.
15. Mishra D., Mishra P., Dubey V., Nahar M., Dabadghao S., Jain N.K. Systemic and mucosal immune response induced by transcutaneous immunization using hepatitis B surface antigen-loaded modified liposomes. Eur J Pharm Sci 2008, 33:424-433.
16. Dayan N., Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000, 21:1879-1885.
17. Toteva M.M., Zanon R., Ostovic D. Kinetics and mechanism of the hydrolytic degradation of indinavir. Intramolecular catalysis. J Pharm Sci 2007, 97:3810-3819.
18. Dubey V., Mishra D., Asthana A., Jain N.K. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials 2006, 27:3491-3496.
19. Fry D.W., White J.C., Goldman I.D. Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem 1978, 90:809-815.
20. Sorensen E.N., Weisman G., Vidaver G.A. A Sephadex column for measuring uptake and loss of low molecular weight solutes from small vesicles. Anal Biochem 1977, 82:376-384.
21. Lopez-Pinto J.M., Gonzalez-Rodriguez M.L., Rabasco A.M. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 2000, 298:1-12.
22. Celia C., Trapasso E., Cosco D., Paolino D., Fresta M. Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surfaces Biointerfaces 2009, 72:155-160.
23. Weiss R.A. How HIV does causes AIDS. Science 1993, 260:1273-1278.
24. Barry A.L., Cullis P.R. Direct NMR evidence for ethanol binding to the lipid-water interface of phospholipid bilayers. Biochemistry 1995, 33:8082-8088.
25. Lasic D., Weiner N., Riaz M., Martin F., Liposomes. In: Lieberman A., Rieger M., Banker G., editors: Pharmaceutical dosage forms: disperse systems. Vol 3. New York: Marcel Dekker; 1998. p. 43-86.
26. Verma D.D., Verma S., Blume G., Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003, 258:141-151.
27. Choi S.U., Bui T., Ho R.J. pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute. J Pharm Sci 2008, 97:931-943.
28. Paolino D., Lucania G., Mardente D., Alhaique F., Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo skin anti-inflammatory activity on human volunteers. J Control Release 2005, 106:99-110.
29. Lodzki M., Godin B., Rakou L., Mechoulam R., Gallily R., Touitou E. Cannabidol-transdermal delivery and anti-inflammatory effect in murine model. J Control Release 2003, 93:377-387.
30. Harrison J.H., Groundwater P.W., Brain K.R., Hadgraft J. Azone induced fluidity in human stratum corneum. A Fourier transform infrared spectroscopy investigation using predeuterated analogue. J Control Release 1996, 41:283-290.
31. Jacobs M., Martin G.P., Marriott C. Effects of phosphatidylcholine in the topical bioavailability of corticosteroids assessed by the human skin blanching assay. J Pharm Pharmacol 1988, 40:829-833.
32. Honeywell-Nguyen P.L., de Graff A.M., Wouter Gronink H.W., Bouwstra J.A. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim Biophys Acta 2002, 1573:130-140.